Intrexon ActoBiotics, a wholly-owned subsidiary of Intrexon Corporation (NASDAQ: XON), decided to create a new brand to communicate their scientific breakthroughs. We were asked to develop a new brand identity and support them in all communications.
Various hard copy and digital communication assets including new website, corporate presentations, custom disease icons, full rebranding (concept, logo, brand promise, tagline).
About the Client
ActoBio Therapeutics™ is pioneering a new class of safe, effective and easy-to-use treatments called ActoBiotics® for autoimmune and allergic disorders based on the well-characterized food-grade bacterium Lactococcus lactis. For more information, visit www.actobio.com